Dermatology, Phlebology and Fluid Mechanics Research Laboratory, St Vincent's Centre for Applied Medical Research (AMR), St. Vincent's Hospital, Sydney, Australia.
St Vincent's Clinical School, Faculty of Medicine, The University of New South Wales, Sydney, Australia.
Phlebology. 2021 Dec;36(10):771-778. doi: 10.1177/02683555211018312. Epub 2021 May 27.
Contrast agents are used widely in the interventional setting and in particularly in the management of vascular anomalies and have also been used in combination with sclero-embolic agents. There is limited information on the interaction of contrast agents with sclerosant agents when used as mixtures. The aim of this study was to determine the effect of mixing radiological contrast agents with detergent sclerosants and measuring the effect on change in lytic activity of detergent sclerosants and by proxy the change in potency.
Red blood cell lysis was assessed following the incubation of two commonly used contrast agents, LIPIODOL® and ULTRAVIST®, mixed with detergent sclerosants, FIBROVEIN®, sodium tetradecyl sulfate (STS), and AETHOXYSKLEROL®, polidocanol (POL).
The density of both contrast agents was higher than STS and POL and neither of the detergent sclerosants were miscible in LIPIODOL. LIPIODOL on its own caused cell lysis (1.01%, p < 0.05) whereas ULTRAVIST did not. Fifty per cent cell lysis for sclerosant and LIPIODOL mix occurred at concentrations of: 0.041% (2.4 times greater than the control, p < 0.05) and 0.08% (3.6 times greater than the control, p = 0.06) for STS and POL, respectively.
LIPIODOL, when mixed with sclerosant detergents (ratio 1:1) causes a reduction in the lytic activity of sclerosants and this effect was statistically significant and most prominent in lower sclerosant concentration mixtures.
对比剂在介入治疗中广泛应用,尤其在血管畸形的治疗中,也与硬化栓塞剂联合应用。关于将对比剂与硬化剂混合使用时的相互作用,信息有限。本研究旨在确定将放射学对比剂与去污剂硬化剂混合使用时的影响,并测量对去污剂硬化剂的溶细胞活性变化的影响,间接测量其效力变化。
将两种常用的对比剂 LIPIODOL®和 ULTRAVIST®与去污剂硬化剂 FIBROVEIN®、十四烷基硫酸钠(STS)和 AETHOXYSKLEROL®、聚多卡醇(POL)混合后,评估红细胞裂解情况。
两种对比剂的密度均高于 STS 和 POL,且 LIPIODOL 与任何一种去污剂硬化剂均不混溶。LIPIODOL 本身可引起细胞裂解(1.01%,p<0.05),而 ULTRAVIST 则不会。对于 STS 和 POL,硬化剂与 LIPIODOL 混合物达到 50%细胞裂解的浓度分别为:0.041%(比对照高 2.4 倍,p<0.05)和 0.08%(比对照高 3.6 倍,p=0.06)。
LIPIODOL 与硬化剂去污剂混合(比例为 1:1)可降低硬化剂的溶细胞活性,这种作用具有统计学意义,且在较低的硬化剂浓度混合物中最为明显。